rosiglitazone has been researched along with Carcinoma, Non-Small Cell Lung in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loong, HHF; To, KKW; Wu, WKK | 1 |
| Han, S; Ritzenthaler, JD; Roman, J; Sun, X; Zheng, Y | 1 |
| Choudhary, R; Li, H; Nemenoff, RA; Sorenson, AL; Weiser-Evans, MC; Winn, RA | 1 |
| Andersen, ME; Chen, Y; Dong, J; Fu, J; Hou, Y; Pi, J; Qu, W; Tokar, EJ; Waalkes, MP; Wang, A; Woods, CG; Xu, Y; Xue, P; Yarborough, K; Zhan, L; Zhang, H; Zhang, Q | 1 |
| Han, S; Rivera, HN; Roman, J | 1 |
| Hur, GY; In, KH; Jung, HC; Jung, KH; Kang, KH; Kim, JH; Lee, SY; Shim, JJ; Shin, C; Yoo, SH | 1 |
| Han, S; Roman, J | 1 |
| Batra, RK; Cui, X; Dubinett, SM; Hazra, S; Sharma, S; Tai, HH | 1 |
| Ahn, JH; Cheon, HG; Kim, KY | 1 |
9 other study(ies) available for rosiglitazone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy.
Topics: Antineoplastic Agents; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; PPAR gamma; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Quinazolines; Rosiglitazone; Thiazolidinediones | 2018 |
Rosiglitazone inhibits alpha4 nicotinic acetylcholine receptor expression in human lung carcinoma cells through peroxisome proliferator-activated receptor gamma-independent signals.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Humans; Lung Neoplasms; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Receptors, Nicotinic; Rosiglitazone; Signal Transduction; Thiazolidinediones; Tumor Suppressor Protein p53 | 2009 |
Peroxisome proliferator-activated receptor-gamma inhibits transformed growth of non-small cell lung cancer cells through selective suppression of Snail.
Topics: Adenocarcinoma; Blotting, Western; Cadherins; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooxygenase 2; Glycogen Synthase Kinase 3; Humans; Hypoglycemic Agents; Lung Neoplasms; Matrix Metalloproteinases; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Snail Family Transcription Factors; Thiazolidinediones; Transcription Factors | 2010 |
Regulatory role of KEAP1 and NRF2 in PPARĪ³ expression and chemoresistance in human non-small-cell lung carcinoma cells.
Topics: Antineoplastic Agents; Antioxidant Response Elements; Arsenic Trioxide; Arsenicals; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation; Gene Knockdown Techniques; Glutamate-Cysteine Ligase; Heme Oxygenase-1; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; Models, Biological; NAD(P)H Dehydrogenase (Quinone); Neoplastic Stem Cells; NF-E2-Related Factor 2; Oxides; PPAR gamma; Proto-Oncogene Mas; RNA Interference; Rosiglitazone; Thiazolidinediones | 2012 |
Peroxisome proliferator-activated receptor-gamma ligands inhibit alpha5 integrin gene transcription in non-small cell lung carcinoma cells.
Topics: Base Sequence; Benzophenones; Binding Sites; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; DNA, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Integrin alpha5; Ligands; Phosphorylation; PPAR gamma; Promoter Regions, Genetic; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Tyrosine | 2005 |
PPAR-gamma agonist increase gefitinib's antitumor activity through PTEN expression.
Topics: Antineoplastic Agents; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Dose-Response Relationship, Drug; Gefitinib; Humans; Lung Neoplasms; PPAR gamma; PTEN Phosphohydrolase; Quinazolines; Rosiglitazone; Statistics, Nonparametric; Thiazolidinediones; Tumor Cells, Cultured | 2006 |
Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways.
Topics: AMP-Activated Protein Kinases; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Humans; Lung Neoplasms; Multienzyme Complexes; Phosphorylation; PPAR gamma; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; Rosiglitazone; Signal Transduction; Thiazolidinediones; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2006 |
Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase.
Topics: Carcinoma, Non-Small-Cell Lung; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Humans; Hydroxyprostaglandin Dehydrogenases; Hypoglycemic Agents; Membrane Proteins; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones; Up-Regulation | 2007 |
Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
Topics: Apoptosis; Benzhydryl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Epoxy Compounds; Formazans; Humans; Indenes; Lung Neoplasms; Morpholines; PPAR gamma; Proline Oxidase; Reactive Oxygen Species; RNA Interference; Rosiglitazone; Tetrazolium Salts; Thiazolidinediones | 2007 |